Research and Innovation
Dartmouth-Hitchcock Health to Fund $1M Annually for Dedicated Cancer Clinician Research Time
A new program will create dedicated time to assist Dartmouth-Hitchcock Health clinicians in researching causes of and cures for cancer.
Modernizing Cancer Care with Machine Learning
Dartmouth researchers are leading the way on cutting-edge computer technologies that could provide clinicians with great new tools for cancer screening, diagnosis, prognosis and more.
New Machine Learning Method Could Spare Some Women from Unnecessary Breast Surgery
A new machine learning method can predict the likelihood that a high-risk type of breast lesion is cancerous, potentially saving some women from unnecessary breast surgeries and overtreatment.
Where Do Prouty Donations Go? Fall 2018
Norris Cotton Cancer Center researchers begin five new pilot research projects funded by money raised at the 37th annual Prouty.
Spurring Innovation in Cancer Research
A gift from the Quinn family launches a new program at Norris Cotton Cancer Center that supports investigators working to transition promising drugs and devices from the laboratory to clinical use.
Combating Direct Tumor Cell Communication in Pancreatic Cancer
A new Norris Cotton Cancer Center study looks at disrupting communication networks between pancreatic cancer cells as a promising new approach to treatment.
Where Do Prouty Donations Go? Spring 2018
Thanks to community-raised Prouty Pilot funding, Norris Cotton Cancer Center researchers and their Dartmouth collaborators are underway with novel cancer research.
What's Happening with Pancreatic Cancer Research at NCCC?
NCCC’s leading pancreatic cancer research experts highlight groundbreaking research projects and clinical trials underway for this challenging cancer, and offer thoughts on what the future holds.
Where do Prouty Donations Go? Fall, 2017
The five newest Dartmouth-Hitchcock Norris Cotton Cancer Center pilot research projects are underway, funded by money raised at the 35th annual Prouty.
NCCC Melanoma Research Goes Skin-Deep in a New Clinical Trial
Still enjoying life eight years after being given a six percent chance of surviving metastatic melanoma, Nancy Calder joins a new NCCC clinical trial to contribute to finding a cure.